CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Norway
Summary
Norway is a mature healthcare market, with a strong focus on healthcare spending.Norway spends 10.5% of its GDP on healthcare that is the third highest in the world. The health system is mostly publicly financed, primarily through a national insurance tax.The national insurance, or social security, is a collective compulsory insurance plan for Norwegian citizens.The healthcare sector employs about 454,000 people with around 166,000 in the government sector and 76,000 in the private sector.
Value of the Norwegian pharmaceutical market increased from $2.18 billion in 2010 to $2.37 billion in 2017, at a compound annual growth rate (CAGR) of 1.2%. The Over-The Counter (OTC) market was $770m in 2012 and increased to $1,040m in 2017 at a CAGR of 7.8%.The medical device market increased from $1.31 billion in 2010 to $1.71 billion in 2017. The market is expected to grow at a CAGR of 4.9% from $1.79 billion in 2018 to $2.17 billion in 2022.
In 2017, there were about 1,951,522 patients at general hospitals with 534,103 in-patients, 273,596 day-care patients and 1,788,371 out-patients.The increasing elderly population and high investment in R&D expenditure are expected to drive the growth of healthcare market. However, generic substitution and parallel imports pose as a barrier for the pharmaceutical companies
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Norway, forms an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Norway. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Norway. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Norway, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Pfizer, Merck, Leo Pharma, Bayer and Vistin Pharma) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Philips Healthcare, Roche Diagnostics, Essilor and Photocure)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Norway
- Porter’s five forces analysis for pharmaceutical and medical devices market of Norway
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Norwegian healthcare market
Reasons to buyThis report will enhance your decision-making capability by allowing you to - - Develop business strategies by understanding the trends shaping and driving the Norwegian healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Norwegian healthcare market
- Executive Summary
- Overview of Pharmaceutical Market
- Overview of Medical Device Market
- Deals Analysis
- Porter’s Five Forces Model
- Market Access
- Country Healthcare Landscape
- Opportunities and Challenges
- Appendix
- List of Tables
- Table 1: OTC Market, Norway, Top Product Sales ($m), 2017
- Table 2: Pharmaceutical Market, Norway, Pharmaceutical Sales by Therapeutic Area ($m), 2017
- Table 3: IVD Devices Market, Norway, Revenue ($m) and Market Share (%) of Major Companies, 2017
- Table 4: Ophthalmic Devices Market, Norway, Revenue ($m) and Market Share (%) of Major Companies, 2015
- Table 5: Orthopedic Devices Market, Norway, Revenue ($m) and Market Share (%) of Major Companies, 2016
- Table 6: Healthcare IT Market, Norway, Revenue ($m) and Market Share (%) of Major Companies, 2016
- Table 7: Cardiovascular Devices Market, Norway, Revenue ($m) and Market Share (%) of Major Companies, 2017
- Table 8: Reimbursement Categories and Rates, Norway, 2015
- Table 9: National Insurance Contribution Rates, Norway, 2016
- Table 10: Pricing Procedures, Norway, 2015
- Table 11: Market Authorization Fees, Norway, 2018
- Table 12: Types of Import Authorizations for Clinical Studies, Norway, 2017
- Table 13: Patent Fees, Norway, 2017
- Table 14: Trademark Fees, Norway, 2017
- Table 15: Clinical Trial Regulation, Norway, 2017
- Table 16: Advertising Regulations, Norway, 2017
- Table 17: Labeling and Packaging Regulations, Norway, 2017
- Table 18: Nordic Package
- Table 19: Trade Fairs, Norway, 2018-2019
- List of Figures
- Figure 1: Pharmaceutical Market, Norway, Revenue ($bn), 2010-2017
- Figure 2: Medical Device Market, Norway, Revenue ($bn), 2010-2017
- Figure 3: Country Profile, Norway, 2017
- Figure 4: Pharmaceutical Market, Norway, Revenue ($bn), 2010-2017
- Figure 5: Pharmaceutical Market, Norway, Revenue Forecast ($bn), 2018-2022
- Figure 6: Pharmaceutical Exports ($bn), Norway, 2010-2016
- Figure 7: Top Export Partners, Norway, 2016
- Figure 8: Pharmaceutical Imports ($bn), Norway, 2010-2016
- Figure 9: Top Import Partners, Norway, 2016
- Figure 10: Pharmaceutical Value Chain, Norway, 2017
- Figure 11: Pharmaceutical Market, Norway, Pharmaceutical Sales by Therapeutic Area($m), 2017
- Figure 12: Pharmaceutical Market, Norway, Major Players
- Figure 13: Medical Device Market, Norway, Revenue ($bn), 2010-2017
- Figure 14: Medical Device Market, Norway, Revenue Forecast ($bn), 2018-2022
- Figure 15: Medical Device Market, Norway, Revenue by Segment ($m), 2017
- Figure 16: IVD Devices Market, Norway, Revenue ($m), 2010-2017
- Figure 17: IVD Devices Market, Norway, Market Share of Major Players (%), 2017
- Figure 18: Ophthalmic Devices Market, Norway, Revenue ($m), 2010-2017
- Figure 19: Ophthalmic Devices Market, Norway, Market Share of Major Players (%), 2015
- Figure 20: Orthopedic Devices Market, Norway, Revenue ($m), 2010-2017
- Figure 21: Orthopedic Devices Market, Norway, Market Share of Major Players (%), 2016
- Figure 22: Healthcare IT Market, Norway, Revenue ($m), 2010-2017
- Figure 23: Healthcare IT Market, Norway, Market Share of Major Players (%), 2016
- Figure 24: Cardiovascular Devices Market, Norway, Revenue ($m), 2010-2017
- Figure 25: Cardiovascular Devices Market, Norway, Market Share of Major Companies (%), 2017
- Figure 26: Diagnostic Market, Norway, Revenue ($m), 2010-2017
- Figure 27: Diagnostic Market, Norway, Revenue ($m), 2018-2022
- Figure 28: Medical Device Market, Norway, Revenue ($bn) of Major Companies, 2016
- Figure 29: Deal Value and Deal Count, Pharmaceutical Market, Norway, 2017-2018
- Figure 30: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Norway, 2017-2018
- Figure 31: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Norway, 2017-2018
- Figure 32: Pharmaceutical Market, Norway, Top Five Therapy Areas by Deal Value ($m), 2017-2018
- Figure 33: Pharmaceutical Market, Norway, Top Five Therapy Areas by Deal Number, 2017-2018
- Figure 34: Pharmaceutical Market, Norway, M&A Deals by Therapy Area, 2017-2018
- Figure 35: Pharmaceutical Market, Norway, Venture Financing Deals by Therapy Area, 2017-2018
- Figure 36: Medical Device Market Deals by Deal Value ($m), Norway, 2017-2018
- Figure 37: Medical Device Market Deals by Deal Count, Norway, 2017-2018
- Figure 38: Medical Device Market Deals Share by Deal Count, Norway, 2017-2018
- Figure 39: Medical Device Market Deals Share (by deal value), Norway, 2017-2018
- Figure 40: Medical Device, Norway, Top Therapy Area by Deal Value, 2017-2018
- Figure 41: Medical Devices, Norway, Top Therapy Area by Deal Number, 2017-2018
- Figure 42: Medical Devices, Norway, M&A Deals by Therapy Area, 2017-2018
- Figure 43: Medical Devices, Norway, Venture Financing Deals by Therapy Area, 2017-2018
- Figure 44: Medical Devices, Norway, Private Equity Deals by Therapy Area, 2017-2018
- Figure 45: Organization of the Health System, Norway, 2016
- Figure 46: Decision Making Process, Norway, 2015
- Figure 47: Out-of-Pocket Expenditure (% of total expenditure on health), Norway, 2010-2016
- Figure 48: Annual Rate of Change (%), Health Price Index, Norway, 2010-2017
- Figure 49: Norway Medicines Agency, Organization Chart, 2017
- Figure 50: National Procedure, Norway, 2017
- Figure 51: Centralized Procedure, Norway, 2017
- Figure 52: Decentralized Procedure, Norway, 2017
- Figure 53: Medical Device Market Deals Share (by deal value), Norway, 2017-2018
- Figure 54: Medical Device, Norway, Top Therapy Area by Deal Value, 2017-2018
- Figure 55: Mutual Recognition Procedure, Norway, 2017
- Figure 56: Conformity Assessment of Class I Medical Devices, EU, 2017
- Figure 57: Conformity Assessment of Class IIa Medical Devices, EU, 2017
- Figure 58: Conformity Assessment of Class IIb Medical Devices, EU, 2017
- Figure 59: Conformity Assessment of Class III Medical Devices, EU, 2017
- Figure 60: European Patent Approval Process, EU, 2017
- Figure 61: Number of Hospitals, Norway,2010-2017
- Figure 62: Diagnostic Equipment (per million population), Norway,2010-2017
- Figure 63: Hospital Beds (per 1,000 population), Norway, 2010-2017
- Figure 64: Curative Care Hospital Beds (per 1,000 population), Norway, 2010-2017
- Figure 65: Psychiatric Hospital Beds (per 1,000 population), Norway, 2010-2017
- Figure 66: Life Expectancy (in years), Norway, 2010-2017
- Figure 67: Immunization Rate (%), Norway, 2010-2017
- Figure 68: PM2.5 (μg per m3), Norway, 2010-2017
- Figure 69: CO2 Emissions (metric tons per capita), Norway, 2010-2017
- Figure 70: Physicians (per 1,000 population), Norway, 2010-2017
- Figure 71: Nurses (per 1,000 population), Norway, 2010-2017
- Figure 72: Dentists, (per 1,000 population), Norway, 2010-2017
- Figure 73: Pharmacists, (per 1,000 population), Norway, 2010-2017
- Figure 74: Major Causes of Mortality (Number of Deaths, ‘000), Norway, 2015
- Figure 75: Major Causes of Male Mortality (Number of Deaths, ‘000), Norway, 2015
- Figure 76: Major Causes of Female Mortality (Number of Deaths, ‘000), Norway, 2015
- Figure 77: Disability-Adjusted Life Years by Major Disease (‘000), Norway, 2015
- Figure 78: Healthcare Expenditure as Percentage of GDP (%), Norway, 2010-2017
- Figure 79: Public-Private Share (%), Norway, 2010-2017
- Figure 80: Major Components of Healthcare Expenditure(%), Norway, 2016
- Figure 81: Spending in Pharmaceutical and Healthcare R&D ($m), Norway, 2010-2015
- Figure 82: Opportunities & Challenges, Norway